You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Last Updated: January 20, 2021

DrugPatentWatch Database Preview

Litigation Details for Hikma Pharmaceuticals USA Inc. v. Granules Pharmaceuticals, Inc., USA (D. Del. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Hikma Pharmaceuticals USA Inc. v. Granules Pharmaceuticals, Inc., USA (D. Del. 2018)

Docket   Start Trial Date Filed 2018-01-11
Court District Court, D. Delaware Date Terminated 2019-09-18
Cause 35:271 Patent Infringement Assigned To Colm Felix Connolly
Jury Demand Defendant Referred To
Patents 8,927,607; 9,399,036; 9,555,029; 9,675,613; 9,789,108
Attorneys Charles B. Klein
Firms Heyman Enerio Gattuso & Hirzel LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Hikma Pharmaceuticals USA Inc. v. Granules Pharmaceuticals, Inc., USA
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Hikma Pharmaceuticals USA Inc. v. Granules Pharmaceuticals, Inc., USA (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-01-11 1 .S. Patent Nos. 8,927,607 (the “’607 patent,” attached as Exhibit A), 9,399,036 (the “’036 patent,” attached… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C…9,675,613 (the “’613 patent,” attached as Exhibit D), and 9,789,108 (the “’108 patent,” attached as Exhibit…must include, among other things, the patent number of any patent that claims the drug or a method of … THE PATENTS-IN-SUIT 16. The United States Patent & Trademark Office External link to document
2018-01-11 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,927,607; 9,399,036; 9,555,029… 18 September 2019 1:18-cv-00085 835 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.